Search

everythinglearnresearchcommunity

for

Search:↓

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

CD2 might be a new treatment target for patchy alopecia areata.

Hair loss treatment caused more hair loss in a man.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Topical vitamin D is effective in treating vitiligo with few side effects.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.